PDGFB and neoplasm: Since VM+ tumors are relatively insensitive to angiostatic drugs 10 and angiostatic therapy might even induce VM 12, 13, 17, 37, we explored whether targeting PDGF‐B could prevent vascular formation by VM+ tumor cells.